Biotechnology VALUE FUND II L.P., Director, 10% Owner at XOMA Corp (XOMA), bought 41,249 shares at $18.39 ($770K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market purchase of $770k XOMA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.39 | 3,330 | $61K | 8.0% |
| 2 | $18.39 | 3,330 | $61K | 8.0% |
| 3 | $18.39 | 15,670 | $288K | 37.4% |
| 4 | $18.39 | 15,670 | $288K | 37.4% |
| 5 | $21.98 | 1,573 | $35K | 4.5% |
| 6 | $21.98 | 1,676 |
| $37K |
| 4.8% |
| Total | $18.67 avg | 41,249 | $770K | 100% |
| Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |
| RPTX | BUY | 2022-01-21 | $28.1M | — | Filing → |